HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours.

Abstract
Angiogenesis and extracellular matrix degradation are key events in tumour progression, and factors regulating stromal-epithelial interactions and matrix composition are potential targets for the development of novel anti-invasive/antiangiogenic therapies. Here, we examine the expression of ADAMTS-8, a secreted protease with antiangiogenic properties, in brain tissues. Using quantitative RT-polymerase chain reaction (PCR), high, equivalent expression of ADAMTS-8 was found in normal whole brain, cerebral cortex, frontal lobe, cerebellum and meninges. ADAMTS-8 expression in 34 brain tumours (including 22 high-grade gliomas) and four glioma cell lines indicated at least two-fold reduction in mRNA compared to normal whole brain in all neoplastic tissues, and no detectable expression in 14 out of 34 (41%) tumours or four out of four (100%) cell lines. In contrast, differential expression of TSP1 and VEGF was seen in nine out of 15 (60%) and seven out of 13 (54%) tumours, with no relationship in the expression of these genes. Immunohistochemistry and Western analysis indicated downregulation of ADAMTS-8 protein in >77% tumours. Methylation-specific PCR analysis of ADAMTS-8 indicated promoter hypermethylation in one out of 24 brain tumours (a metastasis) and three out of four glioma cell lines suggesting an alternative mechanism of downregulation. These data suggest a role for ADAMTS-8 in brain tumorigenesis, warranting further investigation into its role in regulation of tumour angiogenesis and local invasion.
AuthorsJ R Dunn, J E Reed, D G du Plessis, E J Shaw, P Reeves, A L Gee, P Warnke, C Walker
JournalBritish journal of cancer (Br J Cancer) Vol. 94 Issue 8 Pg. 1186-93 (Apr 24 2006) ISSN: 0007-0920 [Print] England
PMID16570050 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Cell Cycle Proteins
  • RNA, Messenger
  • TSPY1 protein, human
  • Vascular Endothelial Growth Factor A
  • ADAM Proteins
  • ADAMTS Proteins
  • ADAMTS8 protein, human
Topics
  • ADAM Proteins (genetics, metabolism, pharmacology)
  • ADAMTS Proteins
  • Angiogenesis Inhibitors (genetics, metabolism, pharmacology)
  • Binding Sites
  • Blotting, Western
  • Brain Neoplasms (metabolism)
  • Cell Cycle Proteins (genetics, metabolism)
  • Cell Line, Tumor
  • Down-Regulation
  • Gene Expression Profiling
  • Humans
  • Methylation
  • Promoter Regions, Genetic
  • RNA, Messenger (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Vascular Endothelial Growth Factor A (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: